These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 32009283)

  • 21. Hepatitis C Virus Infection in Persons Who Inject Drugs in the Middle East and North Africa: Intervention Strategies.
    Khalsa JH; Mathur P
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C among people who inject drugs in Tbilisi, Georgia: an urgent need for prevention and treatment.
    Bouscaillou J; Champagnat J; Luhmann N; Avril E; Inaridze I; Miollany V; Labartkava K; Kirtadze I; Butsashvili M; Kamkamidze G; Pataut D
    Int J Drug Policy; 2014 Sep; 25(5):871-8. PubMed ID: 24529802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa sub-region of the Middle East and North Africa.
    Chaabna K; Mohamoud YA; Chemaitelly H; Mumtaz GR; Abu-Raddad LJ
    Syst Rev; 2014 Dec; 3():146. PubMed ID: 25516265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.
    Akiyama MJ; Cleland CM; Lizcano JA; Cherutich P; Kurth AE
    Lancet Infect Dis; 2019 Nov; 19(11):1255-1263. PubMed ID: 31540840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis.
    Chemaitelly H; Chaabna K; Abu-Raddad LJ
    PLoS One; 2015; 10(8):e0135281. PubMed ID: 26296200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
    Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
    Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sub-genotypes of hepatitis C virus in the Middle East and North Africa: Patterns of distribution and temporal changes.
    Athamneh RY; Abudalo R; Sallam M; Alqudah A; Alquran H; Amawi KF; Abu-Harirah HA
    Infect Genet Evol; 2023 Apr; 109():105412. PubMed ID: 36791585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada.
    Fortier E; Artenie AA; Zang G; Jutras-Aswad D; Roy É; Grebely J; Bruneau J
    Addiction; 2019 Aug; 114(8):1495-1503. PubMed ID: 30957310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Socio-demographic and ecological factors associated with anti-HCV prevalence in people who inject drugs: A systematic review.
    Colledge S; Leung J; Grebely J; Degenhardt L; Peacock A; Hickman M; Vickerman P; Stone J; Trickey A; Larney S
    Drug Alcohol Depend; 2020 Apr; 209():107899. PubMed ID: 32086179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses.
    Mahmud S; Akbarzadeh V; Abu-Raddad LJ
    Sci Rep; 2018 Jan; 8(1):150. PubMed ID: 29317673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.
    Ramia S; Melhem NM; Kreidieh K
    Infection; 2012 Feb; 40(1):1-10. PubMed ID: 22237470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
    BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global prevalence of HCV and/or HBV coinfections among people who inject drugs and female sex workers who live with HIV/AIDS: a systematic review and meta-analysis.
    Rashti R; Alavian SM; Moradi Y; Sharafi H; Mohamadi Bolbanabad A; Roshani D; Moradi G
    Arch Virol; 2020 Sep; 165(9):1947-1958. PubMed ID: 32617764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia.
    Handanagic S; Sevic S; Barbaric J; Dominkovic Z; Dakovic Rode O; Begovac J; Bozicevic I
    Drug Alcohol Depend; 2017 Feb; 171():132-139. PubMed ID: 28088084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.
    Arum C; Fraser H; Artenie AA; Bivegete S; Trickey A; Alary M; Astemborski J; Iversen J; Lim AG; MacGregor L; Morris M; Ong JJ; Platt L; Sack-Davis R; van Santen DK; Solomon SS; Sypsa V; Valencia J; Van Den Boom W; Walker JG; Ward Z; Stone J; Vickerman P;
    Lancet Public Health; 2021 May; 6(5):e309-e323. PubMed ID: 33780656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
    Degenhardt L; Webb P; Colledge-Frisby S; Ireland J; Wheeler A; Ottaviano S; Willing A; Kairouz A; Cunningham EB; Hajarizadeh B; Leung J; Tran LT; Price O; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Grebely J
    Lancet Glob Health; 2023 May; 11(5):e659-e672. PubMed ID: 36996857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes.
    Ruta S; Cernescu C
    World J Gastroenterol; 2015 Oct; 21(38):10811-23. PubMed ID: 26478672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
    Solomon SS; McFall AM; Lucas GM; Srikrishnan AK; Kumar MS; Anand S; Quinn TC; Celentano DD; Mehta SH
    PLoS Med; 2017 Nov; 14(11):e1002460. PubMed ID: 29182638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global genotype distribution of hepatitis C viral infection among people who inject drugs.
    Robaeys G; Bielen R; Azar DG; Razavi H; Nevens F
    J Hepatol; 2016 Dec; 65(6):1094-1103. PubMed ID: 27520879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C antibody prevalence and behavioral correlates in people who inject drugs attending harm reduction services in Lisbon, Portugal.
    Curado A; Nogueira PJ; Virgolino A; Santa Maria J; Mendão L; Furtado C; Antunes F
    Front Public Health; 2022; 10():952909. PubMed ID: 36081480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.